301075 多瑞醫藥
按盤價 
57.000 +0.990 (+1.768%)
57.000 +0.990 (+1.768%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.869 | -16.331 | -8.651 | 2.475 | 2.655 |
| 總資產報酬率 ROA (%) | 0.889 | -7.251 | -4.807 | 1.913 | 2.343 |
| 投入資產回報率 ROIC (%) | 1.313 | -10.734 | -6.293 | 2.074 | 2.449 | 邊際利潤分析 |
| 銷售毛利率 (%) | 11.204 | 8.173 | 42.415 | 68.552 | 76.981 |
| 營業利潤率 (%) | 4.928 | -83.264 | -35.641 | 6.637 | 5.300 |
| 息稅前利潤/營業總收入 (%) | 13.478 | -74.293 | -34.305 | 5.295 | 3.316 |
| 淨利潤/營業總收入 (%) | 3.388 | -85.877 | -35.335 | 5.113 | 4.634 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -673.076 | 91.450 | 87.826 | 16.708 | 59.917 |
| 價值變動淨收益/利潤總額(%) | 643.498 | -0.678 | -6.847 | 25.662 | 0.054 |
| 營業外收支淨額/利潤總額(%) | 24.554 | 2.271 | 0.010 | 0.277 | -1.101 | 償債能力分析 |
| 流動比率 (X) | 0.661 | 0.744 | 1.238 | 5.024 | 4.478 |
| 速動比率 (X) | 0.440 | 0.555 | 1.148 | 4.767 | 4.252 |
| 資產負債率 (%) | 46.578 | 51.408 | 50.913 | 23.370 | 16.182 |
| 帶息債務/全部投入資本 (%) | 11.451 | 19.382 | 21.298 | 19.278 | 12.196 |
| 股東權益/帶息債務 (%) | 651.664 | 339.653 | 308.203 | 416.939 | 719.075 |
| 股東權益/負債合計 (%) | 108.082 | 87.090 | 86.592 | 308.101 | 516.675 |
| 利息保障倍數 (X) | 1.940 | -6.812 | -25.609 | -3.893 | -1.722 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 169.954 | 213.640 | 136.615 | 91.088 | 84.255 |
| 存貨周轉天數 (天) | 202.831 | 164.504 | 102.593 | 112.825 | 83.045 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
